COVID-19 webinar: “Black fungus” in the Indian subcontinent – prevention and cure

Mayo Clinic experts discuss the probable causes of the COVID-19 associated rhino-orbital mucormycosis (“black fungus”) crisis in India, as well as therapeutic strategies for COVID-19 that can help to mitigate risks. In addition to medical and surgical treatment options, the role of monoclonal antibodies in high-risk patients are addressed.

  • Moderator: Amit K. Ghosh, M.D., M.B.A., consultant, Division of General Internal Medicine; professor of medicine
  • Featured Expert: Devyani Lal, M.D., dean of education, Mayo Clinic in Arizona; chair, Division of Rhinology, Mayo Clinic in Arizona; professor of otolaryngology
  • Featured Expert: Arun Kumar Agarwal, D.Sc., medical advisor, Innovation, Education and Clinical Excellence, Apollo Hospitals Group
  • Featured Expert: Alok Thakar, M.S., F.R.C.S., professor and chair, Department of Otolaryngology & Head-Neck Surgery, All India Institute of Medical Sciences, New Delhi
  • Featured Expert: Holenarasipur (Vik) R. Vikram, M.D., consultant, Division of Infectious Diseases, Mayo Clinic in Arizona; professor of medicine


Click here to claim credit and view faculty disclosures. Select Register to begin the credit claim process.


The views and perspectives shared in these resources are presented based on information available at the time of recording.